{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T07:11:10Z","timestamp":1719558670143},"reference-count":37,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Cardiovasc. Med."],"DOI":"10.3389\/fcvm.2015.00002","type":"journal-article","created":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T16:05:48Z","timestamp":1422979548000},"source":"Crossref","is-referenced-by-count":2,"title":["The Challenges of Arterial Hypertension"],"prefix":"10.3389","volume":"2","author":[{"given":"Gian Paolo","family":"Rossi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2015,2,3]]},"reference":[{"issue":"7","key":"B1","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1001\/jama.213.7.1143","article-title":"Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg","volume":"213","year":"1970","journal-title":"JAMA"},{"issue":"23","key":"B2","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1001\/jama.242.23.2572","article-title":"Five-year findings of the hypertension detection and follow-up program. II. Mortality by race-sex and age. hypertension detection and follow-up program cooperative group","volume":"242","year":"1979","journal-title":"JAMA"},{"issue":"Suppl 2","key":"B3","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1097\/00005344-198507002-00003","article-title":"Cardiovascular morbidity and mortality in mild hypertension: the Australian trial","volume":"7","author":"Doyle","year":"1985","journal-title":"J Cardiovasc Pharmacol"},{"issue":"10","key":"B4","first-page":"S5","article-title":"Blood pressure, antihypertensive treatment and stroke risk","volume":"12","author":"MacMahon","year":"1994","journal-title":"J Hypertens Suppl"},{"issue":"7050","key":"B5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/bmj.313.7050.147","article-title":"Blood pressure and risk of stroke in patients with cerebrovascular disease. The United Kingdom Transient Ischaemic Attack Collaborative Group","volume":"313","author":"Rodgers","year":"1996","journal-title":"BMJ"},{"key":"B6","doi-asserted-by":"publisher","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"issue":"1","key":"B7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/00004872-200401000-00003","article-title":"Worldwide prevalence of hypertension: a systematic review","volume":"22","author":"Kearney","year":"2004","journal-title":"J Hypertens"},{"issue":"9623","key":"B8","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0140-6736(08)60655-8","article-title":"Global burden of blood-pressure-related disease, 2001","volume":"371","author":"Lawes","year":"2008","journal-title":"Lancet"},{"issue":"4","key":"B9","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/01.hjh.0000163158.14493.23","article-title":"Prevalence and correlates of left atrial enlargement in essential hypertension: role of ventricular geometry and the metabolic syndrome: the evaluation of target organ damage in hypertension study","volume":"23","author":"Cuspidi","year":"2005","journal-title":"J Hypertens"},{"issue":"13","key":"B10","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1161\/CIRCULATIONAHA.111.068064","article-title":"Incidence and prognosis of resistant hypertension in hypertensive patients","volume":"125","author":"Daugherty","year":"2012","journal-title":"Circulation"},{"issue":"6","key":"B11","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1097\/00004872-200306000-00001","article-title":"2003 European society of hypertension-European society of cardiology guidelines for the management of arterial hypertension","volume":"21","author":"European Society of Hypertension-European Society of Cardiology Guidelines Committee","year":"2003","journal-title":"J Hypertens"},{"issue":"6","key":"B12","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC)","volume":"25","author":"Mancia","year":"2007","journal-title":"J Hypertens"},{"issue":"9","key":"B13","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1097\/HJH.0b013e32832f4f6b","article-title":"Management of high blood pressure in children and adolescents: recommendations of the European society of hypertension","volume":"27","author":"Lurbe","year":"2009","journal-title":"J Hypertens"},{"issue":"6","key":"B14","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3109\/08037050903450468","article-title":"Reappraisal of European guidelines on hypertension management: a European society of hypertension task force document","volume":"18","author":"Mancia","year":"2009","journal-title":"Blood Press"},{"issue":"10","key":"B15","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1097\/HJH.0b013e328364ca4c","article-title":"2013 Practice guidelines for the management of arterial hypertension of the European society of hypertension (ESH) and the European society of cardiology (ESC): ESH\/ESC task force for the management of arterial hypertension","volume":"31","author":"ESH\/ESC Task Force for the Management of Arterial Hypertension","year":"2013","journal-title":"J Hypertens"},{"key":"B16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.113.01316","article-title":"Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism","volume":"62","author":"Rossi","year":"2013","journal-title":"Hypertension"},{"issue":"9","key":"B17","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"B18","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"B19","doi-asserted-by":"publisher","first-page":"705","DOI":"10.7326\/0003-4819-129-9-199811010-00005","article-title":"A clinical prediction rule for renal artery stenosis","volume":"129","author":"Krijnen","year":"1998","journal-title":"Ann Intern Med"},{"issue":"1","key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00281-009-0146-7","article-title":"Atherosclerosis is an inflammatory disease","volume":"31","author":"Montecucco","year":"2009","journal-title":"Semin Immunopathol"},{"issue":"2","key":"B21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0094-0143(21)00939-3","article-title":"Role of duplex ultrasonography in screening for significant renal artery disease","volume":"21","author":"Olin","year":"1994","journal-title":"Urol Clin North Am"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu072","article-title":"Treatment of atherosclerotic renovascular hypertension: review of observational studies and a meta-analysis of randomized clinical trials","author":"Caielli","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"8058","key":"B23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(78)90500-7","article-title":"Transluminal dilatation of coronary-artery stenosis","volume":"1","author":"Gruntzig","year":"1978","journal-title":"Lancet"},{"issue":"2","key":"B24","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/ccd.22416","article-title":"Kiss my astral: one seriously flawed study of renal stenting after another","volume":"75","author":"White","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"issue":"5","key":"B25","first-page":"701","article-title":"Renal angioplasty and stenting: is it still indicated after ASTRAL and STAR studies?","volume":"51","author":"Henry","year":"2010","journal-title":"J Cardiovasc Surg (Torino)"},{"issue":"3","key":"B26","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1053\/j.semvascsurg.2011.11.001","article-title":"Influence and critique of the ASTRAL and CORAL Trials","volume":"24","author":"Sarac","year":"2011","journal-title":"Semin Vasc Surg"},{"issue":"4","key":"B27","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/ccd.25263","article-title":"Blood pressure response to renal artery stenting in 901 patients from five prospective multicenter FDA-approved trials","volume":"83","author":"Weinberg","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"B28","doi-asserted-by":"publisher","first-page":"CD002944","DOI":"10.1002\/14651858.CD002944.pub2","article-title":"Balloon angioplasty, with and without stenting, versus medical therapy for hypertensive patients with renal artery stenosis","volume":"12","author":"Jenks","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"B29","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1001\/jamainternmed.2014.4332","article-title":"Renal artery revascularization: updated meta-analysis with the CORAL trial","volume":"174","author":"Bavry","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"11","key":"B30","doi-asserted-by":"publisher","first-page":"e463","DOI":"10.1161\/CIRCULATIONAHA.106.174526","article-title":"ACC\/AHA 2005 Practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery\/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC\/AHA task force on practice guidelines (Writing committee to develop guidelines for the management of patients with peripheral arterial disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation","volume":"113","author":"Hirsch","year":"2006","journal-title":"Circulation"},{"issue":"3","key":"B31","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/jhh.2012.21","article-title":"Prospective appraisal of the prevalence of primary aldosteronism in hypertensive patients presenting with atrial flutter or fibrillation (PAPPHY Study): rationale and study design","volume":"27","author":"Rossi","year":"2013","journal-title":"J Hum Hypertens"},{"issue":"11","key":"B32","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1210\/en.2014-1416","article-title":"GPER-1 and estrogen receptor-beta ligands modulate aldosterone synthesis","volume":"155","author":"Caroccia","year":"2014","journal-title":"Endocrinology"},{"issue":"6018","key":"B33","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"issue":"7","key":"B34","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1073\/pnas.1121407109","article-title":"Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5","volume":"109","author":"Scholl","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"B35","doi-asserted-by":"publisher","first-page":"E1861","DOI":"10.1210\/jc.2013-2428","article-title":"A novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III","volume":"98","author":"Monticone","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"7164","key":"B36","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/nature06258","article-title":"A second generation human haplotype map of over 3.1 million SNPs","volume":"449","author":"Frazer","year":"2007","journal-title":"Nature"},{"key":"B37","doi-asserted-by":"publisher","first-page":"D913","DOI":"10.1093\/nar\/gkm1009","article-title":"The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge","volume":"36","author":"Hernandez-Boussard","year":"2008","journal-title":"Nucleic Acids Res"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T11:00:07Z","timestamp":1651143607000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fcvm.2015.00002\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,3]]},"references-count":37,"URL":"https:\/\/doi.org\/10.3389\/fcvm.2015.00002","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,3]]}}}